B Lynne Parshall Cytokinetics Inc (CYTK) insider trading activity

B Lynne Parshall is Director of CYTOKINETICS INC. Currently has a direct ownership of 20,600 shares of CYTK, which is worth approximately $1.01 Million. The most recent transaction as insider was on Sep 09, 2024, when has been sold 5,000 shares (Common Stock) at a price of $54.92 per share, resulting in proceeds of $274,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.6K

0% 3M change

37.33% 12M change

Total Value Held $1.01 Million

B LYNNE PARSHALL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 09 2024	SELL Open market or private sale	$274,600 $54.92 p/Share	5,000 Reduced 19.53%	20,600 Common Stock
Sep 09 2024	BUY Exercise of conversion of derivative security	$108,050 $21.61 p/Share	5,000 Added 16.34%	25,600 Common Stock
Aug 26 2024	SELL Open market or private sale	$286,300 $57.26 p/Share	5,000 Reduced 19.53%	20,600 Common Stock
Aug 26 2024	BUY Exercise of conversion of derivative security	$108,050 $21.61 p/Share	5,000 Added 16.34%	25,600 Common Stock
Aug 12 2024	SELL Open market or private sale	$276,000 $55.2 p/Share	5,000 Reduced 19.53%	20,600 Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	$108,050 $21.61 p/Share	5,000 Added 16.34%	25,600 Common Stock
Jul 29 2024	SELL Open market or private sale	$299,200 $59.84 p/Share	5,000 Reduced 19.53%	20,600 Common Stock
Jul 29 2024	BUY Exercise of conversion of derivative security	$108,050 $21.61 p/Share	5,000 Added 16.34%	25,600 Common Stock
Jul 15 2024	SELL Open market or private sale	$279,100 $55.82 p/Share	5,000 Reduced 19.53%	20,600 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	$53,400 $10.68 p/Share	5,000 Added 16.34%	25,600 Common Stock
Jul 01 2024	SELL Open market or private sale	$271,100 $54.22 p/Share	5,000 Reduced 19.53%	20,600 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$53,400 $10.68 p/Share	5,000 Added 16.34%	25,600 Common Stock
Jun 17 2024	SELL Open market or private sale	$262,750 $52.55 p/Share	5,000 Reduced 19.53%	20,600 Common Stock
Jun 17 2024	BUY Exercise of conversion of derivative security	$53,400 $10.68 p/Share	5,000 Added 16.34%	25,600 Common Stock
Jun 03 2024	SELL Open market or private sale	$243,200 $48.64 p/Share	5,000 Reduced 24.27%	15,600 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$53,400 $10.68 p/Share	5,000 Added 19.53%	20,600 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	5,600 Added 21.37%	20,600 Common Stock
May 10 2023	BUY Grant, award, or other acquisition	-	5,000 Added 25.0%	15,000 Common Stock
Sep 01 2022	SELL Open market or private sale	$1,599,326 $52.79 p/Share	30,296 Reduced 75.18%	10,000 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	$252,669 $8.34 p/Share	30,296 Added 42.92%	40,296 Common Stock
May 10 2022	BUY Grant, award, or other acquisition	-	5,000 Added 33.33%	10,000 Common Stock
Nov 05 2021	SELL Open market or private sale	$1,239,840 $40.0 p/Share	30,996 Reduced 86.11%	5,000 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$312,130 $10.07 p/Share	30,996 Added 79.9%	7,798 Common Stock
Oct 19 2021	SELL Open market or private sale	$369,162 $35.73 p/Share	10,332 Reduced 67.39%	5,000 Common Stock
Oct 19 2021	BUY Exercise of conversion of derivative security	$69,431 $6.72 p/Share	10,332 Added 43.66%	13,333 Common Stock

Also insider at

IONS

IONIS PHARMACEUTICALS INC Healthcare

Director

FHTX

Foghorn Therapeutics Inc. Healthcare

BLP

B Lynne Parshall

Director

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Value

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK

Account